Science

Pipeline

Partnering

Capella BioScience discovers and develops mAbs both independently and in collaboration with biotechnology and academic partners.

We are employing our proprietary technologies to discover, develop and commercialise monoclonal antibody medicines to difficult and novel drug targets.

Partnering

If you would like to find out more about Capella BioScience, please get in touch.